Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07682298Recruiting
Measuring leftover fluid in hospitalized heart failure patients
This study looks at how well we can measure leftover fluid in the body in people hospitalized for heart failure with fluid overload. It aims to help doctors better manage treatment and improve recovery.
AarhusAges 18 years+ - NCT05947916Recruiting
Continuous glucose monitor for type 2 diabetes in pregnancy
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
Beijing, Beijing MunicipalityAges 18–40 - NCT06906835Recruiting
Comparing two blood tests to guide iron treatment in dialysis patients
This trial tests whether a new blood test (reticulocyte hemoglobin) is better than the usual iron test (transferrin saturation) for guiding when to give iron to people on dialysis. If you have anemia (low red blood cells) from kidney disease, this study may help doctors find the best way to treat your iron levels.
Pathumwan, BangkokAges 18–80 - NCT06906744Recruiting
Study of signal loss in fetal heart monitoring during labor
This study looks at why signal loss happens during external fetal heart monitoring in labor. The goal is to improve monitoring for future pregnancies.
StrasbourgAges 18–45 - NCT05745233Enrolling by invitation
Testing immune therapy put into the belly for cancer fluid
This trial studies whether an immune-blocking drug placed directly into the belly cavity can help people with cancer-caused fluid buildup (malignant ascites) from stomach, pancreas, or bile-duct cancers. It may help shrink the fluid and slow the illness, but you must meet specific safety and treatment-history requirements.
Taichung, Please SelectAges 20 years+ - NCT06892184Recruiting
How the dentist talks during numbing injections
This study tests whether the way your dentist communicates with you during a numbing shot (para-apical anesthesia) affects your pain and comfort. It may help find the best way to talk to patients during dental procedures.
Clermont-FerrandAges 18 years+ - NCT06906328Recruiting
ADHD and addiction: can cognitive training help?
This study tests whether adding a cognitive remediation program to methylphenidate (a medication for ADHD) improves treatment response in adults who have both ADHD and a substance use or behavioral addiction. It aims to help patients manage symptoms better over the short and medium term.
Brest, Brittany RegionAges 18–99 - NCT05856383Recruiting
HER2-positive metastatic breast cancer drug combination study
This trial tests whether inetetamab combined with pyrotinib and vinorelbine works better and is safe for adults with HER2-positive advanced breast cancer. You may be considered if standard options have not removed the cancer with surgery and your body can handle chemotherapy and HER2-targeting medicines.
Hangzhou, ZhejiangAges 18 years+ - NCT06904820Recruiting
Hepatitis and HIV screening for drug users
This trial tests a convenient way to screen people who use drugs or are in vulnerable situations for hepatitis B, C, and HIV using rapid tests and a liver scanner. The goal is to see if offering these tests in community settings (like shelters or mobile clinics) is acceptable and works well.
LimogesAges 18 years+ - NCT06904794Recruiting
Teens and gambling after COVID-19: a digital escape room
This study looks at gambling habits among teens after COVID-19 and tests a digital escape room to help prevent gambling in high school students ages 16 to 18.
Zaragoza, ZaragozaAges 16–18 - NCT06728189RecruitingPhase 1
CD70-targeted CAR-NKT cells for advanced solid tumors
This trial tests a new type of immune cell therapy (CAR-NKT cells) that targets a protein called CD70 on cancer cells. It is for people with advanced solid tumors that have not responded to at least two prior treatments.
BeijingAges 18–75 - NCT03717792Recruiting
Check how doctors follow up vascular liver disease
This study focuses on people who have vascular liver disease and aims to evaluate follow-up care and non-invasive ways to assess it. It may help improve how safely and accurately doctors monitor your liver without invasive procedures.
BonnAges 18–100 - NCT06902987RecruitingPhase 1
Upatinib for anal fistulas in Crohn's disease
This trial tests whether upatinib can help heal active anal fistulas in people with moderate to severe Crohn's disease. If you have an anal fistula that is causing pain or drainage, this study may offer a new treatment option.
Guangzhou, GuangdongAges 18–70 - NCT05925504RecruitingPhase 2
Lowering luspatercept dose for lower-risk myelodysplastic anemia
This Phase 2 study tests whether gradually lowering the dose of luspatercept can help people with lower-risk myelodysplastic syndromes (MDS) who have anemia. It may help reduce side effects while still improving blood counts or symptoms.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05925023Recruiting
Sirolimus for warm autoimmune hemolytic anemia after steroid failure
This trial studies sirolimus in adults with “warm” autoimmune hemolytic anemia (or Evans syndrome) when steroids have not worked or the anemia has returned. It may help control the immune attack on red blood cells, but there are specific safety checks for liver health and infections.
Beijing, Beijing MunicipalityAges 18–90 - NCT06902389RecruitingPhase 1/Phase 2
Multi-target immune cell therapy for advanced liver cancer
This trial tests a new type of immune cell therapy (multi-target Hi-TCR-T cells) for people with advanced liver cancer that hasn't responded to earlier treatments. The therapy targets several markers on your cancer cells to try to attack the tumor more effectively.
Shanghai, Yangpu DistrictAges 18–75 - NCT05858684RecruitingEarly Phase 1
CAR-T therapy for hard-to-control lupus
This early-phase study tests a special immune therapy (CAR-T cells) made to target disease-driving immune cells in adults with lupus that has not improved despite standard treatments. It may offer a new option for people with severe, active lupus symptoms.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06900257Enrolling by invitation
Fetal heart function in fasting pregnant women
This study looks at how babies' hearts work when mothers have been fasting for at least 10 days. It may help understand if fasting affects the baby's heart health.
SanliurfaAges 18–50 - NCT05662280Recruiting
Brain stimulation study for teens with ADHD and memory trouble
This study tests whether changing brain activity can improve working memory in teens who have ADHD and trouble remembering and holding information in mind. You and your parent will answer questionnaires, and brain imaging/brain-stimulation testing (MRI/TMS) may be used, with compensation for each session.
East Providence, Rhode IslandAges 12–18 - NCT06900179Enrolling by invitation
Augmented reality education for cancer wound care nurses
This trial tests whether using augmented reality (a technology that adds digital information to what you see) can help nurses learn how to manage cancerous wounds that have a bad odor or discharge. If you are an oncology nurse at a teaching hospital in northern Taiwan, you may be able to join and learn new ways to care for these wounds.
New Taipei City, New Taipei CityAges 20 years+ - NCT06700681Enrolling by invitation
Comparing two sedatives for heart ablation procedures
This trial compares two sedative medicines (remimazolam and propofol) given during heart ablation procedures. The study uses brain-wave monitoring to see which medicine provides better sedation and recovery. It's for people who are already scheduled for this procedure with a specific doctor.
TaipeiAges 20–80 - NCT05861830RecruitingPhase 3
Dalpiciclib plus hormone therapy after CDK4/6 treatment
This trial tests dalpiciclib together with hormone (endocrine) therapy in people with HR-positive, HER2-negative advanced breast cancer whose cancer has already responded poorly to a prior CDK4/6 inhibitor. It aims to see if this combination can better control the cancer after that earlier treatment has failed.
Beijing, Beijing MunicipalityAges 18–80 - NCT06895733RecruitingPhase 1/Phase 2
Pazopanib plus palbociclib for advanced solid tumors with 11q13 change
This trial tests two pills (pazopanib and palbociclib) together for people with advanced solid tumors that have a specific gene change (11q13 amplification) and have stopped responding to other treatments. The goal is to see if this combination can shrink tumors or slow their growth.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT05862818Recruiting
Food timing study to see if it lowers diabetes risk
This study looks at whether changing when you eat can reduce the chance of developing diabetes. You’d need to be generally healthy and meet specific lifestyle and body-size requirements.
Boston, MassachusettsAges 18–45
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.